Computer simulation of protein malfunction related to Alzheimer's disease
Researchers at Universitat Autònoma de Barcelona (UAB) and University of Stockholm have created a computer modelling of the structural malfunctioning of the ApoE4 protein when it enters into contact with the Amyloid beta molecule, the main cause of Alzheimer's disease. The research, published in PLoS Computational biology, supports experimental evidence that links ApoE4 with this pathology and opens up new exploration possibilities in understanding and fighting against the disease.
The research proposes a three-dimensional model which simulates the interaction between the peptide Amyloid beta and the different forms of Apolipoprotein E (ApoE) and offers a first molecular base for the comprehension of this phenomenon. Three possible ApoE forms exist in humans: ApoE2, ApoE3 and ApoE4. ApoE3 is the most common form, while ApoE4 is very closely linked to Alzheimer's disease.
The project was carried out by five researchers, including Jean-Didier Maréchal and Àlex Perálvarez, lecturers at the UAB Departments of Chemistry and of Biochemistry and Molecular Biology (Centre for Biophysics Studies). Given the difficulty in carrying out in vitro experiments with the peptide Amyloid beta, researchers decided to create a computer simulation to establish the first approximation of the molecular mechanisms which relate it to ApoE4.
The developed model structurally reaffirms the experimental observations which link ApoE4 to this pathology. Researchers have observed that this protein tends to lose its functional structure in presence of the peptide Amyloid beta; this however does not occur with the ApoE2 and ApoE3 forms. According to researchers, these differences are due to subtle divergences between the structures of each form and would explain the different responses of carriers of forms 3 and 4 in the presence of Amyloid beta molecules.
The loss of the structure reveals the possibility of new explorations aimed at better understanding and fighting against Alzheimer's disease. The following stage of the study will consist in experimentally characterising this interaction, which is an essential aspect in the design of future therapies. Researchers also highlight that this project has made even more obvious the need for computer tools in all fields of research and of the new possibilities they represent in improving the study of complex molecular systems.
Original publication: Luo J, Maréchal JD, Wärmländer S, Gräslund A, Perálvarez-Marín A.; "In silico analysis of the apolipoprotein e and the amyloid Beta Peptide interaction: misfolding induced by frustration of the salt bridge network."; PLoS Comput Biol. 2010.
Other news from the department science
Most read news
More news from our other portals
Last viewed contents
AI tailors artificial DNA for future drug development - DNA molecules made-to-order: “What otherwise takes years is now shortened to weeks or days”
Merck Expands Corporate Venture Fund M Ventures with a New Investment of € 600 Million - “Over the past decade, M Ventures has established itself globally as a leading partner to the biotech and tech venture ecosystems”
Bacterial soundtracks revealed by graphene membrane - Have you ever wondered if bacteria make distinctive sounds?
BioNTech to Raise USD 250 Million in Private Placement - The private placement includes an investment in ordinary shares and a investment in 4-year mandatory convertible notes
Eurofins opens new faciltiy in Livingston
Improving therapies for GI tumors
Actelion submits the registration dossier for macitentan to EMA
ProtAffin AG strengthens Scientific Advisory Board
Study of skin biopsies offers potential as new diagnostic marker for Amyotrophic Lateral Sclerosis - The discovery of this biomarker detectable in small skin samples can be very useful for cases in which diagnosis is difficult
Memory in neural circuits
Fatal overproduction of antibodies - Mutations in plasma cells play a key role in light chain amyloidosis
